Multi-gene vaccination against malaria: A multistage, multi-immune response approach (Q44161286)

30 November 2017

title

Multi-gene vaccination against malaria: A multistage, multi-immune response approach (English)

1 reference

30 November 2017

0 references

2

Hoffman SL

1 reference

30 November 2017

Doolan DL

1

1 reference

30 November 2017

publication date

1 May 1997

1 reference

30 November 2017

published in

Trends in Parasitology

1 reference

30 November 2017

volume

13

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

171-178

1 reference

Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Antigenic variation in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Specificity of Protective Immunity produced by X-irradiated Plasmodium berghei Sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Immunization of man against sporozite-induced falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Gamma-globulin and acquired immunity to human malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Changes in infectiousness of malarial gametocytes. II. Analysis of the possible causative factors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Host age as a determinant of naturally acquired immunity to Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA. 3. DEVELOPMENT OF ANTIBODIES TO PLASMODIUM FALCIPARUM IN SEMI-IMMUNE PATIENTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Continuous temperature measurements during malaria infections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Safety considerations for nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Assuring the safety and efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Potential DNA vaccine integration into host cell genome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Inability of Malaria Vaccine to Induce Antibodies to a Protective Epitope Within Its Sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Genetic vaccination against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

Immunization against malaria with a recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

An estimation of the number of malaria sporozoites ejected by a feeding mosquito

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901040-5

7 January 2021

10.1016/S0169-4758(97)01040-5

Identifiers

DOI

1 reference

30 November 2017

1 reference